About Us

THE ANTICONVULSANT DRUG DEVELOPMENT PROGRAM WOULD LIKE TO THANK OUR SUPPORTERS

This symposium is made possible through support from:



  • Charles River Laboratories
  • Citizens United for Research in Epilepsy (CURE)
  • Cyberonics
  • Eisai Co., Ltd.
  • Epilepsy Foundation
  • Lundbeck Pharmaceuticals
  • National Institute for Neurological Disorders & Stroke (NINDS)
  • Neuroscience Initiative at the University of Utah
  • Sunovian Pharmaceuticals
  • Supernus Pharmaceuticals
  • UCB Pharmaceuticals